In this study, escitalopram treatment resulted in significantly greater improvement compared with duloxetine on the prospectively defined primary efficacy endpoint of change from baseline in MADRS ...

Chinese-owned carmaker MG looks to be closer to officially unveiling a new ute, and its upcoming dual-cab could be the one which finally comes to Australia. CarNewsChina shared a photo of what’s ...

The MG ZS is a compact crossover that was first released in 2017 and by 2021 had become Australia's top-selling small SUV on the back of keen pricing and a value-packed equipment list. It was aided in ...

Is the MG ZS a good car? MG is going from strength to strength in the UK, with new models appearing left, right and centre, including this latest ZS. From the brilliant MG3 hybrid supermini to the ...

Is the MG ZS a good car? MG is going from strength to strength in the UK, with new models appearing left, right and centre, including this latest ZS. From the brilliant MG3 hybrid supermini to the ...

The successor to the MG ZS EV electric SUV appears set to be known as the 2025 MG S5 EV in Australia when the new model arrives in showrooms next year. It is set to be available with three battery ...

In 2011, following professional reassessment, she suspended the use of Mirtazapine and introduced the SSRI antidepressant, Escitalopram (10 mg, 1 tablet in the morning). The medication was effective ...

In Malaysia, the MG Cyberster can only be obtained in one variant which has a dual motor all-wheel drive (AWD) setup. Price-wise, the MG Cyberster is available in Malaysia for RM319,900. In terms of ...

The international-spec MG Cyberster EV comes with a 77 kWh battery pack that has a WLTP-rated range of more than 500 km The Cyberster EV will be the first roadster from MG in India. It will be ...

Your browser does not support the audio element. The MG Cyberster will launch in India in January 2025, the brand has confirmed. The Cyberster, which was showcased in ...

Patients were treated with either escitalopram 10--20 mg/day (fixed at 10 mg/day for the first 4 weeks) or duloxetine 60 mg/day. The primary efficacy variable was change from baseline at week 8 in ...